The latest update is out from Zymeworks ( (ZYME) ).
Zymeworks Inc. announced the resignation of Mr. Hollings C. Renton from its board of directors, effective December 10, 2024. His departure was amicable, with no disagreements over company operations or policies. In response, Dr. Neil Gallagher was appointed to the compensation committee, and Dr. Susan Mahony will serve as the new chair, signaling a strategic shift in the board’s composition.
Find detailed analytics on ZYME stock on TipRanks’ Stock Analysis page.